Ethical preparedness and developments in genomic healthcare.
Ethics
Genomics
Innovation
Preparedness
Journal
Journal of medical ethics
ISSN: 1473-4257
Titre abrégé: J Med Ethics
Pays: England
ID NLM: 7513619
Informations de publication
Date de publication:
02 Jun 2023
02 Jun 2023
Historique:
received:
11
07
2022
accepted:
17
05
2023
medline:
3
6
2023
pubmed:
3
6
2023
entrez:
2
6
2023
Statut:
aheadofprint
Résumé
Considerations of the notion of preparedness have come to the fore in the recent pandemic, highlighting a need to be better prepared to deal with sudden, unexpected and unwanted events. However, the concept of preparedness is also important in relation to planned for and desired interventions resulting from healthcare innovations. We describe ethical preparedness as a necessary component for the successful delivery of novel healthcare innovations, and use recent advances in genomic healthcare as an example. We suggest that practitioners and organisations charged with delivering innovative and ambitious healthcare programmes can only succeed if they are able to exhibit the attribute of ethical preparedness.
Identifiants
pubmed: 37268409
pii: jme-2022-108528
doi: 10.1136/jme-2022-108528
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: Both BF and AML have served as members of the Genomics England Ethics Advisory Committee. BF is a current member of Our Future Health’s Ethics Advisory Board and a former HFEA Board member. AML is a co-founder of Genethics Forum. AML is Chair of UK Biobank Ethics Advisory Committee. AML is Chair of the Joint Committee of Genomics in Medicine.